Intuitive Surgical (ISRG) shares are up slightly over 3% in the past 12 months although the ride certainly has been wild. Randy Bateman, senior economist at Balcones Investment Research, said investors should stick with the industry leader despite the volatility. 'Their products are so superior to the market that its competitors cannot measure up,' said Bateman, adding that investors may want to use options to gain exposure to the stock because of its high price and rapid movements. Bateman also points to the company’s strong quarterly performance as a fundamental reason to get into the shares. Intuitive Surgical recently reported fourth quarter earnings adjusted for one-time gains and costs of $5.89 per share, surpassing Wall Street expectations of $5.01. The robotic surgery system company posted revenue of $676.5 million in the period, also topping Street forecasts. Sticking with the robotics theme, Bateman is bullish on iRobot (IRBT), which has seen its shares gain over 11% in the past year.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.